الفرق بين المراجعتين لصفحة: «قالب:مضادات الطفيليات/المنخربات الملونة»

من موسوعة العلوم العربية
اذهب إلى التنقل اذهب إلى البحث
(أنشأ الصفحة ب'{{Navbox | name = مضادات الطفيليات المنخربة الصبغية | title = مضادات الطفيليات – [[عامل مضاد للأوالي...')
 
لا ملخص تعديل
سطر 1: سطر 1:
{{Navbox
{{Navbox
| name = مضادات الطفيليات المنخربة الصبغية
| name       = Chromalveolate antiparasitics
| title = [[مضادات الطفيليات]] – [[عامل مضاد للأوالي|العوامل المضادة للأوالي]] مضادات الطفيليات [[منخربة صبغية|المنخربة الصبغية]] ([[ATC code P01|P01]])  
| title     = [[Antiparasitic]]s – [[antiprotozoal agent]]s – [[Chromalveolate]] antiparasitics ([[ATC code P01|P01]])
| state = {{{state<includeonly>|autocollapse</includeonly>}}}
| listclass  = hlist
| state     = {{{state<includeonly>|autocollapse</includeonly>}}}
| groupstyle = background:PowderBlue;
| groupstyle = background:PowderBlue;
| belowstyle = background:#ADFF2F; 


|group1 =[[منخربات|المنخربات]]
| group1     = [[Alveolate|Alveo-<br>late]]
|list1  = {{Navbox subgroup
| list1     =
| groupstyle = background:PowderBlue;
   {{Navbox|subgroup
  | groupstyle = background:PowderBlue;


| group1 =[[Apicomplexa|Apicom-<BR>plexa]]
  | group1     = [[Apicomplexa|Apicom-<br>plexa]]
| list1 = {{Navbox subgroup
  | list1     =
| groupstyle = background:PowderBlue;  
    {{Navbox|subgroup
    | groupstyle = background:PowderBlue;


| group1 =[[Conoidasida]]/<BR>([[Coccidiostat]]s)
    | group1     = [[Conoidasida]]/<br>([[Coccidiostat]]s)
| list1 = {{Navbox subgroup
    | list1     =
| groupstyle = background:PowderBlue;  
      {{Navbox|subgroup
      | groupstyle = background:PowderBlue;


| group1 =[[Cryptosporidiosis#Treatment|Cryptosporidiosis]]
      | group1 = [[Cryptosporidiosis#Treatment|Cryptosporidiosis]]
| list1  = ''[[ثيازول]]'' ([[Nitazoxanide]])
      | list1  =  
* ''[[thiazole]]'' ([[nitazoxanide]])


| group2 =[[Isosporiasis#Treatment|Isosporiasis]]
      | group2 = [[Isosporiasis#Treatment|Isosporiasis]]
| list2  = [[Co-trimoxazole]]<sup>#</sup>
      | list2  =  
* [[trimethoprim/sulfamethoxazole]]<sup>#</sup>


| group3 =[[Toxoplasmosis#Treatment|Toxoplasmosis]]
      | group3 = [[Toxoplasmosis#Treatment|Toxoplasmosis]]
| list3  = [[Pyrimethamine]] [[سلفاديازين]]
      | list3  =  
* [[pyrimethamine]] * [[sulfadiazine]]
  }}


}}
| group2    = [[Aconoidasida]]
| list2      =
  {{Navbox|subgroup
  | groupstyle = background:PowderBlue;


  | group1    = [[Antimalarial drug|Malaria]]
  | list1      =
    {{Navbox|subgroup
    | groupstyle = background:PowderBlue;


| group2 =[[Aconoidasida]]
    | group1    = Individual <br>agents
| list2  = {{Navbox subgroup
    | list1      =
| groupstyle = background:PowderBlue;  
      {{Navbox|subgroup
      | groupstyle = background:PowderBlue;


| group1 =[[دواء مضاد للملاريا|الملاريا]]
      | group1     = [[Hemozoin#Inhibitors|Hemozoin<br>inhibitors]]
| list1 = {{Navbox subgroup
      | list1     =
| groupstyle = background:PowderBlue;
        {{Navbox|subgroup
        | groupstyle = background:PowderBlue;


| group1 =عوامل<BR>منفردة
        | group1 = [[aminoquinoline]]s
| list1  = {{Navbox subgroup
        | list1  =  
| groupstyle = background:PowderBlue;
* (4-): [[amodiaquine]]<sup>#</sup>
* [[chloroquine]]<sup>#</sup>


| group1 =[[هموزوين#المثبطات|مثبطات<BR>الهموزوين]]
* (8-): [[primaquine]]<sup>#</sup>
| list1  = {{Navbox subgroup
* [[pamaquine]]
| groupstyle = background:PowderBlue;


| group1 = [[Aminoquinoline]]s
        | group2 = [[4-methanolquinoline]]s
| list1 = (4-): [[Amodiaquine]]<sup>#</sup> • [[Chloroquine]]<sup>#</sup> <BR> (8-): [[Primaquine]]<sup>#</sup> [[Pamaquine]]
        | list2 =  
* [[mefloquine]]<sup>#</sup> * [[quinine]]<sup>#</sup> * [[quinidine]]


| group2 = [[4-methanolquinoline]]s
        | group3 = Other
| list2 = [[Mefloquine]]<sup>#</sup>• [[Quinine]]<sup>#</sup> • [[Quinidine]]
        | list3 =  
* [[lumefantrine]] * [[artemether/lumefantrine|combined with artemether]]


| group3 = Other
* [[halofantrine]]
| list3  = [[Lumefantrine]] (combined with artemether as [[Coartem]])<BR>[[Halofantrine]]
  }}


| group2    = [[Antifolate]]s
| list2      =
  {{Navbox|subgroup
  | groupstyle = background:PowderBlue;


}}
  | group1 = [[Dihydrofolate reductase inhibitor|DHFR inhibitors]]<br>(antifols)
  | list1  =
* [[pyrimethamine]]  * [[proguanil]]<sup>#</sup> * [[chlorproguanil]] * ''[[biguanide]]s''


| group2 = [[Antifolate]]s
  | group2 = [[Sulfonamide (medicine)|Sulfonamides]]
| list2  = {{Navbox subgroup
  | list2  =  
| groupstyle = background:PowderBlue;
* [[sulfadoxine]] * [[sulfamethoxypyrazine]]


| group1 = [[Dihydrofolate reductase inhibitor|DRI]]s
  | group3 = Coformulation
| list1 = ''[[2,4-Diaminopyrimidine]]s'' ([[Pyrimethamine]]) <BR>''[[biguanide]]s'' ([[Proguanil]]<sup>#</sup> • [[Chlorproguanil]])
  | list3 =  
* [[sulfadoxine/pyrimethamine]] (SP)<sup>#</sup>
  }}


| group2 = [[Dihydropteroate synthetase inhibitor|DSI]]s
| group3 = [[Sesquiterpene lactones|Sesquiterpene<br>lactones]]
| list2 = [[Sulfadoxine]] • Sulfamethoxypyrazine
| list3 =  
* [[artemether]]<sup>#</sup> * [[artesunate]]<sup>#</sup> * [[dihydroartemisinin]] * [[artemotil]] * [[artemisinin]]


| group3 = Combination
| group4 = Other
| list3 = Fansidar<sup>#</sup> (pyrimethamine-sulfadoxine)
| list4 =  
* [[atovaquone]] (with proguanil as Malarone)  * [[tetracycline]] * [[doxycycline]]<sup>#</sup> * [[clindamycin]] * [[pyronaridine]] * [[piperaquine]]


}}
}}


| group3 = [[Sesquiterpene lactones|Sesquiterpene<BR>lactones]]
| groupstyle = background:PowderBlue;
| list3  =  [[Artemether]]<sup>#</sup> • [[Artesunate]]<sup>#</sup>• [[Dihydroartemisinin]] •<BR>  [[Artemotil|Arteether/Artemotil]] • [[Artemisinin]]
 
| group4 = Other
| list4  =  [[Atovaquone]] (combined with proguanil as Malarone) <BR> [[Tetracycline]] • [[Doxycycline]]<sup>#</sup><BR>Clindamycin


}}
| group2    = Combi-<br>nations
| list2      =
  {{Navbox|subgroup
  | groupstyle = background:PowderBlue;


| groupstyle = background:PowderBlue;
  | group1 = Fixed-dose (coformulated)  [[Artemisinin|ACTs]]
| group2 = Combi-<BR>nations
  | list1 =  
| list2 = {{Navbox subgroup
* [[artemether/lumefantrine]]<sup>#</sup> * [[artesunate/amodiaquine]] (ASAQ) * [[artesunate/mefloquine]] (ASMQ) * [[dihydroartemisinin/piperaquine]] * [[artesunate/pyronaridine]]
| groupstyle = background:PowderBlue;


| group1 = Fixed-dose (coformulated)  [[Artemisinin|ACTs]]
  | groupstyle = background:PowderBlue;
| list1  = [[Coartem]]<sup>#</sup>  • [[ASAQ]] (Coarsucam) •  ASMQ •<BR>Duo-Cotecxin (Artekin)


| groupstyle = background:PowderBlue;
  | group3 = Other combinations<br>(not co-formulated)
| group3 = Combination therapies <BR>(not co-formulated)
  | list3  =  
| list3  = Artequin • Ariplus • Co-Arinate • [[Chlorproguanil hydrochloride-dapsone-artesunate|CDA]]
* artesunate/SP * artesunate/mefloquine * quinine/tetracycline * quinine/doxycycline * quinine/clindamycin
| groupstyle = background:PowderBlue;
  | groupstyle = background:PowderBlue;
}}
  }}


}}
}}


| group2 = [[Babesiosis#Treatment|Babesiosis]]
| group2 = [[Babesiosis#Treatment|Babesiosis]]
| list2  = [[Clindamycin]]
| list2  =  
 
* [[clindamycin]]


}}
}}




}}
}}


| group2 = [[Ciliophora|Cilio-<BR>phora]]
| group2 = [[Ciliophora|Cilio-<br>phora]]
| list2  = [[Balantidiasis#Treatment|Balantidiasis]]: [[Tetracycline]]
| list2  =  
* [[Balantidiasis#Treatment|Balantidiasis]]: [[Tetracycline]]


}}  
}}  


|group2 = [[Heterokont|Hetero-<BR>kont]]
| group2 = [[Heterokont|Hetero-<br>kont]]
|list2   = [[Blastocystosis#Treatment|Blastocystosis]]: [[Metronidazole]]
| list2 =  
* [[Blastocystosis#Treatment|Blastocystosis]]: [[Metronidazole]]


| below = {{PharmNavFootnote}}<BR>{{Infection navs}}
| belowstyle = background: transparent; padding: 0px;
| below = {{PharmNavFootnote}}{{CEA navs}}


}}<noinclude>
}}<noinclude>
 
[[تصنيف:جداول تصفح الأدوية]]
[[تصنيف:جداول تصفح الأدوية|{{PAGENAME}}]]
</noinclude>
</noinclude>

مراجعة 18:12، 3 نوفمبر 2013